SBC Medical Group’s (SBC) Buy Rating Reaffirmed at BTIG Research

BTIG Research restated their buy rating on shares of SBC Medical Group (NASDAQ:SBC) in a research report released on Thursday,Benzinga reports. BTIG Research currently has a $8.00 price target on the stock.

A number of other analysts also recently issued reports on the stock. Wall Street Zen upgraded shares of SBC Medical Group to a “hold” rating in a report on Saturday, May 9th. Weiss Ratings downgraded SBC Medical Group from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Friday, May 22nd. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $8.50.

SBC Medical Group Trading Down 0.3%

NASDAQ:SBC opened at $3.19 on Thursday. SBC Medical Group has a one year low of $2.78 and a one year high of $5.07. The company has a debt-to-equity ratio of 0.12, a current ratio of 3.82 and a quick ratio of 3.78. The firm has a market capitalization of $327.23 million, a price-to-earnings ratio of 8.18 and a beta of 0.59. The business has a fifty day moving average price of $3.07 and a 200-day moving average price of $3.56.

SBC Medical Group (NASDAQ:SBC) last posted its quarterly earnings results on Thursday, August 13th. The company reported $0.10 earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.02). SBC Medical Group had a return on equity of 15.90% and a net margin of 24.09%.The firm had revenue of $49.19 million during the quarter, compared to the consensus estimate of $45.37 million. Sell-side analysts forecast that SBC Medical Group will post 0.47 EPS for the current year.

Institutional Trading of SBC Medical Group

Institutional investors have recently modified their holdings of the company. BlackRock Inc. purchased a new position in shares of SBC Medical Group in the 2nd quarter valued at approximately $2,846,000. Geode Capital Management LLC acquired a new stake in SBC Medical Group in the second quarter valued at approximately $455,000. Segall Bryant & Hamill LLC acquired a new stake in SBC Medical Group in the first quarter valued at approximately $340,000. Millennium Management LLC purchased a new stake in shares of SBC Medical Group in the third quarter valued at approximately $219,000. Finally, Bank of New York Mellon Corp acquired a new position in shares of SBC Medical Group during the 2nd quarter worth approximately $83,000. 60.82% of the stock is currently owned by institutional investors.

SBC Medical Group Company Profile

SBC Medical Group, Inc is a publicly traded healthcare management services company listed on the Nasdaq under the ticker SBC. The company specializes in supporting in-office ancillary service providers by offering a suite of administrative and operational solutions designed to streamline practice management and enhance revenue performance. Its core mission is to help physician practices, imaging centers and other ancillary service providers focus on patient care while outsourcing complex back-office functions.

The company’s primary offerings include revenue cycle management, medical billing and coding, compliance oversight and transcription services.